LXRX FY 2011 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$710M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-62.3% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$114M-6170.6% margin

Net Income

-$116M-6285.3% margin

EPS (Diluted)

$-2.39

Cash Flow

Operating Cash Flow

-$88M

Free Cash Flow

-$89M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$431M

Total Liabilities

$133M

Stockholders' Equity

$298M

Cash & Equivalents

$186M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$5M	-62.3%
Gross Profit	$2M	$5M	-62.3%
Operating Income	-$114M	-$96M	-19.2%
Net Income	-$116M	-$102M	-14.2%